Caterina Riillo

Catanzaro, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

UMG1 Defines a Targetable Subset of T-Cell Lymphomas and Enables Precision Immunotherapy With a First-in-Class CD3ε Bispecific Engager.

UMG1 Defines a Targetable Subset of T-Cell Lymphomas and Enables Precision Immunotherapy With a First-in-Class CD3ε Bispecific Engager.

Journal: Hematological oncology

Published: September 24, 2025

Cis- and trans-binding chimeric costimulatory receptors enhance T-cell fitness and tumor control.

Cis- and trans-binding chimeric costimulatory receptors enhance T-cell fitness and tumor control.

Journal: Cellular & molecular immunology

Published: July 15, 2025

Operational burden and fragmented implementation in CAR T-cell therapy: Insights from a multinational survey by the GoCART Coalition and the JACIE Quality Managers Committee.

Operational burden and fragmented implementation in CAR T-cell therapy: Insights from a multinational survey by the GoCART Coalition and the JACIE Quality Managers Committee.

Journal: HemaSphere

Published: July 09, 2025

Disrupting the balance between activating and inhibitory receptors of γδT cells for effective cancer immunotherapy.

Disrupting the balance between activating and inhibitory receptors of γδT cells for effective cancer immunotherapy.

Journal: Nature reviews. Cancer

Published: April 24, 2025

UMG1/CD3ε-bispecific T-cell engager redirects T-cell cytotoxicity against diffuse large B-cell lymphoma.

UMG1/CD3ε-bispecific T-cell engager redirects T-cell cytotoxicity against diffuse large B-cell lymphoma.

Journal: British journal of haematology

Published: August 19, 2023

An unbiased lncRNA dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for multiple myeloma.

An unbiased lncRNA dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for multiple myeloma.

Journal: Blood

Published: August 17, 2023

The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis.

The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis.

Journal: Critical reviews in oncology/hematology

Published: June 20, 2023

First-line systemic treatment for hepatocellular carcinoma: A systematic review and network meta-analysis.

First-line systemic treatment for hepatocellular carcinoma: A systematic review and network meta-analysis.

Journal: Heliyon

Published: May 15, 2023

Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity.

Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity.

Journal: Frontiers in oncology

Published: March 15, 2023

Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP).

Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP).

Journal: Bone marrow transplantation

Published: February 26, 2023

A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer.

A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer.

Journal: Journal of translational medicine

Published: February 20, 2023

The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas.

The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas.

Journal: Cancers

Published: February 13, 2023

Showing 1-12 of 33

Last Updated: 09/26/2026